Latham Advises BC Partners on Acquisition of Havea

Paris corporate team represents leading international investment firm in the transaction.

June 23, 2022

Latham & Watkins has advised BC Partners, a leading international investment firm, on its exclusive negotiations to acquire a majority stake in Havea, the French leader in natural healthcare serving the European market.

The new partnership would support Havea’s best-in-class management team to execute its strategy of strong organic growth, empower it to accelerate its pace of M&A with complementary businesses, and continue investing in digitalisation.

The Latham Paris team was led by corporate partner Denis Criton, with corporate associates Antoine Dufrane, Julia Lefevre, Pierre-Yves Marquet, and Eva Labbé. Advice was provided on tax matters by partner Olivia Rauch-Ravisé with associate Alexis Caminel; on antitrust matters by partner Adrien Giraud with associate Wenceslas Chelini; and on regulatory / life sciences matters by partner Eveline Van Keymeulen with associate Jeanne Fabre. 

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.